Apollomics (APLM) Total Liabilities (2020 - 2025)
Apollomics (APLM) posted quarterly Total Liabilities of $6.7 million for Q4 2025, up 6967.37% year-on-year from $95000.0 in Q4 2024, and up 1365.94% on a QoQ basis from $458000.0 in Q2 2025.
Apollomics (APLM) Total Liabilities (2020 - 2025) Analysis & Trends
Apollomics (APLM) has reported Total Liabilities for 6 consecutive years, with $6.7 million the latest figure, recorded in Q4 2025.
- Quarterly Total Liabilities rose 6967.37% year-over-year to $6.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.7 million (up 6967.37% YoY) and the FY2025 annual result came in at $6.7 million, up 6967.37% from the prior year.
- Total Liabilities climbed to $6.7 million in Q4 2025 per APLM's latest filing, from $458000.0 in the prior quarter.
- Over the last five years, Total Liabilities for APLM reached as high as $511.9 million in Q4 2022 and fell as low as $95000.0 in Q4 2024.
- A 5-year average of $134.6 million and a median of $6.7 million in 2025 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities slumped 99.95% — and 2025, when it jumped 6967.37%.
- Year by year, Total Liabilities stood at $322.2 million in 2021, then soared by 58.86% to $511.9 million in 2022, then sank by 99.95% to $259000.0 in 2023, then slumped by 63.32% to $95000.0 in 2024, then soared by 6967.37% to $6.7 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $6.7 million, $458000.0, and $95000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - | 6.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.71 Mn |
| Jun 30, 2025 | 458,000.00 |
| Dec 31, 2024 | 95,000.00 |
| Jun 30, 2024 | 145,000.00 |
| Dec 31, 2023 | 259,000.00 |
| Jun 30, 2023 | 71.38 Mn |
| Dec 31, 2022 | 511.86 Mn |
| Jun 30, 2022 | 298.55 Mn |
| Dec 31, 2021 | 322.22 Mn |
| Dec 31, 2020 | 284.79 Mn |